Survival After Coronary Revascularization With Paclitaxel-Coated Balloons | Journal of the American College of Cardiology
Mortality risk after use of a paclitaxel-coated stent in femoropopliteal peripheral artery disease | SpringerLink
Peripheral Artery Disease Treatment: Paclitaxel & Sirolimus | VER Journal
Paclitaxel coated balloons for coronary artery interventions: A comprehensive review of preclinical and clinical data - International Journal of Cardiology
Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis: A pooled analysis of the Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent
Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon | JACC: Cardiovascular Interventions
Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing | Open Heart
Paclitaxel-Coated Balloons Compared to Plain Balloon Angioplasty in the Management of Dysfunctional Arteriovenous Fistulae: A Single-Center Randomized Clinical Trial Arabi M, Salman R, Alharbi A, Alzahrani Y, Bashir O, Qazi S, Abdallah
Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing | Open Heart
Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing | Open Heart
Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial - EuroIntervention
The benefits of drug-eluting stents in the treatment of coronary arter | RRCC
Paclitaxel‐eluting balloon: From bench to bed - De Labriolle - 2009 - Catheterization and Cardiovascular Interventions - Wiley Online Library
Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic Patients | NEJM
Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing | Open Heart
Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial - The Lancet
Risk of Mortality with Paclitaxel Drug-Coated Balloon in De Novo Coronary Artery Disease - ScienceDirect
Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing | Open Heart
A Retrospective Look at Paclitaxel Use in the Coronary Arteries - Endovascular Today
Paclitaxel-Coated Balloons Compared to Plain Balloon Angioplasty in the Management of Dysfunctional Arteriovenous Fistulae: A Single-Center Randomized Clinical Trial Arabi M, Salman R, Alharbi A, Alzahrani Y, Bashir O, Qazi S, Abdallah
Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease | JACC: Cardiovascular Interventions
Drug-Eluting Balloon Versus Drug-Eluting Stent for Complex Femoropopliteal Arterial Lesions: The DRASTICO Study | Journal of the American College of Cardiology
Agentᵀᴹ Drug Coated Eluting Balloon - Boston Scientific
